James F Cleary

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. ncbi request reprint The pharmacologic management of cancer pain
    James F Cleary
    Department of Medicine, University of Wisconsin, Madison, Wisconsin 53792, USA
    J Palliat Med 10:1369-94. 2007
  2. pmc Communicating advanced cancer patients' symptoms via the Internet: a pooled analysis of two randomized trials examining caregiver preparedness, physical burden, and negative mood
    Ming Yuan Chih
    Department of Industrial and Systems Engineering, University of Wisconsin Madison, Madison, WI, USA
    Palliat Med 27:533-43. 2013
  3. doi request reprint Multivariate analysis of countries' government and health-care system influences on opioid availability for cancer pain relief and palliative care: more than a function of human development
    Aaron M Gilson
    Pain and Policy Studies Group, University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, WI, USA
    Palliat Med 27:105-14. 2013
  4. pmc An eHealth system supporting palliative care for patients with non-small cell lung cancer: a randomized trial
    David H Gustafson
    Center for Health Enhancement Systems Studies, University of Wisconsin Madison, Madison, Wisconsin 53706, USA
    Cancer 119:1744-51. 2013
  5. pmc Caregivers' participation in the oncology clinic visit mediates the relationship between their information competence and their need fulfillment and clinic visit satisfaction
    Lori L DuBenske
    University of Wisconsin Madison, Center for Health Enhancement Systems Studies, Madison, WI 53726, USA
    Patient Educ Couns 81:S94-9. 2010
  6. pmc Creating a bond between caregivers online: effect on caregivers' coping strategies
    Kang Namkoong
    School of Journalism and Mass Communication, and Center for Health Enhancement Systems Studies, University of Wisconsin, Madison, Wisconsin 53706, USA
    J Health Commun 17:125-40. 2012
  7. pmc Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care?
    Gabrielle B Rocque
    University of Wisconsin, Carbone Cancer Center, Hematology Oncology, K6 518, 600 Highland Ave, Madison, WI 53729, USA
    J Oncol Pract 9:51-4. 2013
  8. doi request reprint Using a morphine equivalence metric to quantify opioid consumption: examining the capacity to provide effective treatment of debilitating pain at the global, regional, and country levels
    Aaron M Gilson
    Pain and Policy Studies Group, University of Wisconsin Carbone Cancer Center, Madison, WI, USA
    J Pain Symptom Manage 45:681-700. 2013
  9. pmc Development and implementation of a clinician reporting system for advanced stage cancer: initial lessons learned
    Lori L DuBenske
    Center for Health Enhancement Systems Studies, University of Wisconsin, Madison, Wisconsin, USA
    J Am Med Inform Assoc 15:679-86. 2008
  10. ncbi request reprint Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer
    Paul R Hutson
    School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705 2222, USA
    Clin Cancer Res 11:8722-7. 2005

Detail Information

Publications29

  1. ncbi request reprint The pharmacologic management of cancer pain
    James F Cleary
    Department of Medicine, University of Wisconsin, Madison, Wisconsin 53792, USA
    J Palliat Med 10:1369-94. 2007
    ..Much of the work obtained from the study of cancer patients is applicable to the non cancer populations, as is work performed in non cancer patients with neuropathic pain...
  2. pmc Communicating advanced cancer patients' symptoms via the Internet: a pooled analysis of two randomized trials examining caregiver preparedness, physical burden, and negative mood
    Ming Yuan Chih
    Department of Industrial and Systems Engineering, University of Wisconsin Madison, Madison, WI, USA
    Palliat Med 27:533-43. 2013
    ..Using available communication technologies, clinicians may offer timely support to family caregivers in managing symptoms in patients with advanced cancer at home...
  3. doi request reprint Multivariate analysis of countries' government and health-care system influences on opioid availability for cancer pain relief and palliative care: more than a function of human development
    Aaron M Gilson
    Pain and Policy Studies Group, University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, WI, USA
    Palliat Med 27:105-14. 2013
    ..Although opioids such as morphine are considered essential medicines in the provision of palliative care and for treating cancer pain, especially when the pain is severe, low- and middle-income countries often lack such medications...
  4. pmc An eHealth system supporting palliative care for patients with non-small cell lung cancer: a randomized trial
    David H Gustafson
    Center for Health Enhancement Systems Studies, University of Wisconsin Madison, Madison, Wisconsin 53706, USA
    Cancer 119:1744-51. 2013
    ....
  5. pmc Caregivers' participation in the oncology clinic visit mediates the relationship between their information competence and their need fulfillment and clinic visit satisfaction
    Lori L DuBenske
    University of Wisconsin Madison, Center for Health Enhancement Systems Studies, Madison, WI 53726, USA
    Patient Educ Couns 81:S94-9. 2010
    ..This study examines the mediating role caregiver's clinic visit involvement has on the relationships between caregiver's information competence and their need fulfillment and clinic visit satisfaction...
  6. pmc Creating a bond between caregivers online: effect on caregivers' coping strategies
    Kang Namkoong
    School of Journalism and Mass Communication, and Center for Health Enhancement Systems Studies, University of Wisconsin, Madison, Wisconsin 53706, USA
    J Health Commun 17:125-40. 2012
    ..Findings suggest that perceived bonding has positive effects on caregivers' appraisal and problem-focused coping strategies, and it mediates the effect of ICCS on the coping strategies 6 months after the intervention has begun...
  7. pmc Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care?
    Gabrielle B Rocque
    University of Wisconsin, Carbone Cancer Center, Hematology Oncology, K6 518, 600 Highland Ave, Madison, WI 53729, USA
    J Oncol Pract 9:51-4. 2013
    ..Many patients receive aggressive, in-hospital end-of-life care at high cost. There are few data on outcomes after unplanned hospitalization of patients with metastatic cancer...
  8. doi request reprint Using a morphine equivalence metric to quantify opioid consumption: examining the capacity to provide effective treatment of debilitating pain at the global, regional, and country levels
    Aaron M Gilson
    Pain and Policy Studies Group, University of Wisconsin Carbone Cancer Center, Madison, WI, USA
    J Pain Symptom Manage 45:681-700. 2013
    ..Understanding opioid consumption is improved by using an equianalgesic measure that controls for the strengths of all examined opioids...
  9. pmc Development and implementation of a clinician reporting system for advanced stage cancer: initial lessons learned
    Lori L DuBenske
    Center for Health Enhancement Systems Studies, University of Wisconsin, Madison, Wisconsin, USA
    J Am Med Inform Assoc 15:679-86. 2008
    ..This study reports initial findings from implementation of the Clinician Report (CR)-a patient and caregiver status report tool accessible by the oncology clinic team...
  10. ncbi request reprint Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer
    Paul R Hutson
    School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705 2222, USA
    Clin Cancer Res 11:8722-7. 2005
    ..Clinical trials combining tamoxifen with letrozole or anastrazole have shown minor pharmacokinetic drug interactions. We did an open-label crossover clinical trial of the effect of exemestane on tamoxifen pharmacokinetics...
  11. ncbi request reprint Endocrine effects of tamoxifen plus exemestane in postmenopausal women with breast cancer
    Richard R Love
    Department of Medicine, University of Wisconsin, 610 Walnut Street, 256 Warf Office Building, Madison, WI 53726, USA
    Clin Cancer Res 11:1500-3. 2005
    ..To evaluate the endocrine effects of the combination of exemestane and tamoxifen, we studied 33 postmenopausal women disease-free following primary treatments for breast cancer who were taking tamoxifen for at least 3 months...
  12. pmc Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies
    Steven Attia
    University of Wisconsin Paul P Carbone Comprehensive Cancer Center Madison, Madison, WI 53792, USA
    Cancer Chemother Pharmacol 64:45-51. 2009
    ..To define dose limiting toxicities (DLTs) and the maximum tolerated dose (MTD) of capecitabine with fixed-dose rate (FDR) gemcitabine...
  13. pmc Web-based cancer communication and decision making systems: connecting patients, caregivers, and clinicians for improved health outcomes
    Lori L DuBenske
    School of Medicine and Public Health, Department of Psychiatry, University of Wisconsin Madison, USA
    Med Decis Making 30:732-44. 2010
    ..Implementation strategies should address timing, personnel, and environmental factors to facilitate continued use and benefit from IHCS...
  14. doi request reprint Cancer information sources used by patients to inform and influence treatment decisions
    Matthew C Walsh
    Paul P Carbone Comprehensive Cancer Center, and Department of Population Health Sciences, University of Wisconsin Madison, Madison, Wisconsin, USA
    J Health Commun 15:445-63. 2010
    ..These findings provide a deeper understanding of the information needs of cancer patients and have implications for dissemination strategies that can minimize disparities in access to cancer information...
  15. doi request reprint Examining influences on the availability of and access to opioids for pain management and palliative care
    Martha A Maurer
    Pain and Policy Studies Group PPSG of the University of Wisconsin Carbone Cancer Center, Madison, Wisconsin 53706, USA
    J Pain Palliat Care Pharmacother 27:255-60. 2013
    ..Recent authoritative statements and activities suggest a strengthened infrastructure within which governments currently can work to improve the availability of controlled medicines to enhance patient pain and palliative care services...
  16. doi request reprint Palliative care reduces morbidity and mortality in cancer
    Gabrielle B Rocque
    Hematology Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI 53792, USA
    Nat Rev Clin Oncol 10:80-9. 2013
    ..Through collaboration between oncologists and palliative care teams, there is hope of improving the quality of care for patients with both curable and life-limiting cancers...
  17. pmc Materials to prepare hospice families for dying in the home
    Karen A Kehl
    School of Nursing, University of Wisconsin, Madison, Wisconsin 53792 2455, USA
    J Palliat Med 11:969-72. 2008
    ..1%), surge of energy (11.8%) and mandibular breathing (5.9%). Hospice staff should know the content of the materials offered by their agency so they can verbally address the gaps between the written materials and family needs...
  18. pmc Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience
    Anne M Traynor
    Section of Hematology and Medical Oncology, University of Wisconsin, Paul P Carbone Comprehensive Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Head Neck 32:599-606. 2010
    ....
  19. doi request reprint Opioid analgesics for pain control: wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices
    Marla Z Wolfert
    University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin WI 53792, USA
    Pain Med 11:425-34. 2010
    ..Although their role in the management of chronic pain not related to cancer is controversial, there is increasing evidence for their benefit in certain patient populations...
  20. pmc Caregivers' differing needs across key experiences of the advanced cancer disease trajectory
    Lori L DuBenske
    Center for Health Enhancement Systems Studies, University of Wisconsin, Madison, Wisconsin 53706, USA
    Palliat Support Care 6:265-72. 2008
    ..This study examines a variety of particular needs across a number of more discrete illness-related transition experiences specifically in the advanced cancer disease trajectory...
  21. ncbi request reprint Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol
    James P Thomas
    University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Medical School, 600 Highland Ave, Madison, WI 53792, USA
    Cancer Chemother Pharmacol 50:465-72. 2002
    ..We conducted a phase I trial and pharmacokinetic study of flavopiridol given as a 72-h continuous intravenous infusion repeated every 2 weeks...
  22. doi request reprint Ensuring patient access to essential medicines while minimizing harmful use: a revised World Health Organization tool to improve national drug control policy
    Aaron M Gilson
    University of Wisconsin Carbone Cancer Center, 1300 University Avenue, Madison, WI 53706, USA
    J Pain Palliat Care Pharmacother 25:246-51. 2011
    ..It is hoped that representatives of governments and medical institutions, as well as health care professionals, will commonly and effectively use the revised WHO guidelines as a policy change tool...
  23. ncbi request reprint Integrating palliative care into head and neck oncology
    James F Cleary
    University of Wisconsin Paul P Carbone Comprehensive Cancer Center, Madison, WI 53792, USA
    Int J Radiat Oncol Biol Phys 69:S83-5. 2007
  24. pmc Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy
    Noelle K Loconte
    University of Wisconsin Paul P Carbone Comprehensive Cancer Center, 600 Highland Ave, CSC K4 548, Madison, WI 53792, USA
    Cancer Chemother Pharmacol 65:775-80. 2010
    ..The goal of this study was to identify clinical and nonclinical factors which were associated with the development of DLT in phase I studies...
  25. pmc Predictors of hospice utilization among acute stroke patients who died within thirty days
    Amanda E duPreez
    Center for Women s Health Research, University of Wisconsin School of Medicine and Public Health and Meriter Hospital, Madison, Wisconsin 53726, USA
    J Palliat Med 11:1249-57. 2008
    ..The highest mortality among stroke patients occurs within the first 30 days; however, we know little about the hospice enrollment decision for this population during this critical time frame...
  26. ncbi request reprint Patient/Caregiver influences for declining participation in supportive oncology trials
    Mary K Buss
    Division of Hematology Oncology and Palliative Care Consultation Service, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Rose 144, Boston, MA 02215, USA
    J Support Oncol 6:168-74. 2008
    ..This information was specific to supportive care trials; it may help researchers plan recruitment strategies and enrollment targets...
  27. ncbi request reprint A day in the life of European palliative care
    James F Cleary
    Palliat Med 19:442-3. 2005
  28. ncbi request reprint Incident pain
    James F Cleary
    Palliat Med 19:1-2. 2005
  29. ncbi request reprint Consensus statement: Palliative and supportive care in advanced heart failure
    Sarah J Goodlin
    Institute for Health Care Delivery and Research, Intermountain Health Care, Salt Lake City, Utah 84111, USA
    J Card Fail 10:200-9. 2004
    ..A consensus conference was convened to define the current state and important gaps in knowledge and needed research on "Palliative and Supportive Care in Advanced Heart Failure."..